Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases.
Proc Natl Acad Sci U S A
; 119(28): e2201423119, 2022 07 12.
Article
in En
| MEDLINE
| ID: mdl-35867758
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Bacterial Toxins
/
Prodrugs
/
Serine Proteases
/
Antigens, Bacterial
/
Antineoplastic Agents
Limits:
Female
/
Humans
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2022
Type:
Article